Stock Analiz

Best biotech stocks

Updated November 16, 2026

We cover 149 US-listed biotech companies. The largest is Amgen Inc. (AMGN), worth $251.9B. These are the 20 with the highest analysis scores today.

How we pick: Biotech stocks with a market cap above $2 billion, ranked by overall score from 0 to 5 (the average of value, future, past, financial health and shareholder returns), then by size.
#CompanyMarket capUpside to fair valueDividendScore
1Exelixis, Inc.EXEL$16.8B+14%—4.4
2Halozyme Therapeutics, Inc.HALO$11.4B+199%—3.4
3Neurocrine Biosciences Inc.NBIX$16.9B+53%—3.0
4Gilead Sciences, Inc.GILD$208.5B-35%1.9%2.8
5Adma Biologics, Inc.ADMA$3.0B-33%—2.8
6BIO-TECHNE CorpTECH$11.4B-60%0.4%2.6
7Amgen Inc.AMGN$251.9B-26%2.2%2.4
8Argenx SEARGX$59.6B-72%—2.4
9Vericel CorpVCEL$2.9B-66%—2.4
10Qiagen NVQGEN$10.3B-37%0.7%2.0
11Krystal Biotech, Inc.KRYS$9.0B+30%—2.0
12Biogen Inc.BIIB$37.5B-33%—1.8
13Repligen Corp.RGEN$10.7B-76%—1.8
14Tarsus Pharmaceuticals, Inc.TARS$4.0B-66%—1.6
15Twist Bioscience CorpTWST$7.4B-98%—1.4
16Adaptive Biotechnologies CorpADPT$4.7B-96%—1.4
17Beam Therapeutics Inc.BEAM$2.4B——1.4
18BioNTech SEBNTX$21.5B-94%—1.2
19ImmunityBio, Inc.IBRX$6.4B——1.2
20Relay Therapeutics, Inc.RLAY$4.0B——1.2

A closer look at the top three

Exelixis, Inc. (EXEL): It has revenue growth of 13% a year over three years, an average net margin of 23%, a P/E of about 21, an intrinsic value about 14% above the current price and an overall score of 4.4 out of 5 (strong company).

Halozyme Therapeutics, Inc. (HALO): It has revenue growth of 28% a year over three years, an average net margin of 33%, a P/E of about 25, an intrinsic value about 199% above the current price and an overall score of 3.4 out of 5 (good, with some weak spots).

Neurocrine Biosciences Inc. (NBIX): It has revenue growth of 24% a year over three years, an average net margin of 15%, a P/E of about 25, an intrinsic value about 53% above the current price and an overall score of 3.0 out of 5 (good, with some weak spots).

Frequently asked questions

What is the best biotech stock right now?

By today’s analysis score, Exelixis, Inc. (EXEL) ranks first with 4.4 out of 5. A score is one measure and does not replace a full analysis.

How many biotech stocks are listed in the US?

Our data covers 149 biotech companies, each with its own analysis page.

How is the 0–5 score calculated?

Each stock faces five numeric tests in each of five areas (value, future, past, financial health and shareholder returns); the overall score is the average of the five.

More lists and tools

Lists are generated automatically from SEC filings and market prices and rebuilt every day. They are a starting point for research, not a recommendation to buy or sell.